Vimta Labs Share Price

NSE
VIMTALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Vimta Labs
Vimta Labs Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Vimta Labs Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
137.83% Gain from 52W Low
17.3
Dividend yield 1yr %
Low in industry
0.2

Vimta Labs Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vimta Labs Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
89.92 Cr
84.74 Cr
81.76 Cr
79.69 Cr
81.68 Cr

Vimta Labs Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
322.27 Cr
321.63 Cr
279.73 Cr
211.51 Cr
183.73 Cr

Vimta Labs Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
17.52 Cr
17.02 Cr
12.28 Cr
12.35 Cr
10.13 Cr

Vimta Labs Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
41.01 Cr
48.17 Cr
41.33 Cr
21.4 Cr
6.84 Cr
Vimta Labs Result Highlights
  • Vimta Labs Ltd reported a 6.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 10.4%.

  • Its expenses for the quarter were up by 5.8% QoQ and down 2.7% YoY.

  • The net profit increased 41.0% QoQ and increased 112.2% YoY.

  • The earnings per share (EPS) of Vimta Labs Ltd stood at 9.6 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Vimta Labs shareholding Pattern

Promoter
36.7%
Foreign Institutions
3.7%
Domestic Institutions
1.4%
Public
58.2%
Promoter
36.8%
Foreign Institutions
3.8%
Mutual Funds
0.1%
Domestic Institutions
1.2%
Public
58.3%
Promoter
36.9%
Foreign Institutions
3.3%
Public
59.8%
Promoter
36.9%
Foreign Institutions
5.2%
Mutual Funds
1.5%
Domestic Institutions
1.4%
Public
56.4%
Promoter
36.9%
Foreign Institutions
5.1%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%

Vimta Labs Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
8
5Day EMA
1,030.80
10Day EMA
1,024.60
12Day EMA
1,021.10
20Day EMA
1,011.70
26Day EMA
1,006.90
50Day EMA
987.70
100Day EMA
931.40
200Day EMA
822.40
5Day SMA
1,060.90
10Day SMA
1,028.90
20Day SMA
990.70
30Day SMA
1,016.40
50Day SMA
995.10
100Day SMA
964.10
150Day SMA
854.70
200Day SMA
780.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
53234 Rs
180504 Rs
Week Rs
110433 Rs
424888 Rs
Month Rs
69842 Rs
251217 Rs
Resistance & Support
1,012.17
Pivot
Resistance
First Resistance
1,033.03
Second Resistance
1,067.17
Third Resistance
1,088.03
Support
First Support
978.03
Second support
957.17
Third Support
923.03
Relative Strength Index
49.41
Money Flow Index
52.50
MACD
14.18
MACD Signal
9.12
Average True Range
79.05
Average Directional Index
17.85
Rate of Change (21)
-4.06
Rate of Change (125)
78.95

Vimta Labs Latest News

29 APR 2025 | Tuesday

Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Newspaper Publication

29 APR 2025 | Tuesday

Q4FY25 & FY25 Result Announced for Vimta Labs Ltd.

28 APR 2025 | Monday

Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

View More

Vimta Labs Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 202324, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.
Read More

Vimta Labs FAQs

Vimta Labs share price is ₹1004 in NSE and ₹1001.75 in BSE as on 30/4/2025.

Vimta Labs share price in the past 1-year return was 86.44. The Vimta Labs share hit a 1-year low of Rs. 420 and a 1-year high of Rs. 1178.

The market cap of Vimta Labs is Rs. 2221.01 Cr. as of 30/4/2025.

The PE ratios of Vimta Labs is 33.33 as of 30/4/2025.

The PB ratios of Vimta Labs is 5.87 as of 30/4/2025

You can easily buy Vimta Labs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Vimta Labs stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -